These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 22980050)
1. Glucocorticoids as mediators of developmental programming effects. Khulan B; Drake AJ Best Pract Res Clin Endocrinol Metab; 2012 Oct; 26(5):689-700. PubMed ID: 22980050 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner. Reynolds RM Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Drake AJ; Tang JI; Nyirenda MJ Clin Sci (Lond); 2007 Sep; 113(5):219-32. PubMed ID: 17663659 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids, prenatal stress and the programming of disease. Harris A; Seckl J Horm Behav; 2011 Mar; 59(3):279-89. PubMed ID: 20591431 [TBL] [Abstract][Full Text] [Related]
12. Prenatal glucocorticoids exposure and fetal adrenal developmental programming. Chen Y; He Z; Chen G; Liu M; Wang H Toxicology; 2019 Dec; 428():152308. PubMed ID: 31614174 [TBL] [Abstract][Full Text] [Related]
13. Environmental influences on placental programming and offspring outcomes following maternal immune activation. Núñez Estevez KJ; Rondón-Ortiz AN; Nguyen JQT; Kentner AC Brain Behav Immun; 2020 Jan; 83():44-55. PubMed ID: 31493445 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of the placental HSD11B2 barrier and its role as a critical regulator of fetal development. Togher KL; Togher KL; O'Keeffe MM; O'Keeffe MM; Khashan AS; Khashan AS; Gutierrez H; Gutierrez H; Kenny LC; Kenny LC; O'Keeffe GW; O'Keeffe GW Epigenetics; 2014 Jun; 9(6):816-22. PubMed ID: 24717516 [TBL] [Abstract][Full Text] [Related]